Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Aldeyra Therapeutics, Inc. | d318309d10k.htm |
| EX-31.1 - EX-31.1 - Aldeyra Therapeutics, Inc. | d318309dex311.htm |
| EX-31.2 - EX-31.2 - Aldeyra Therapeutics, Inc. | d318309dex312.htm |
| EX-32.1 - EX-32.1 - Aldeyra Therapeutics, Inc. | d318309dex321.htm |
| EX-10.25 - EX-10.25 - Aldeyra Therapeutics, Inc. | d318309dex1025.htm |
| EX-10.21 - EX-10.21 - Aldeyra Therapeutics, Inc. | d318309dex1021.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Aldeyra Therapeutics, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-206539) and Form S-8 (Nos. 333-196674, 333-203076, 333-210492 and 333-213045) of Aldeyra Therapeutics, Inc. of our report dated March 30, 2017, relating to the financial statements of Aldeyra Therapeutics, Inc., which appears in this Annual Report on Form 10-K for the year ended December 31, 2016.
/s/ BDO USA, LLP
Boston, Massachusetts
March 30, 2017